Breast Cancer Clinical Trials in Pittsburgh

Showing 481-500 of 614 trials

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

NCT02670577

The scope of this study is to measure the impact of MammaPrint on treatment in Hormone Receptor (HR)-positive HER2-negative breast cancer patients. In addition, the impact of MammaPrint on treatment in patients with T1a/T1b and pN0/pN1 (up to 1 node), Triple Negative or HER2-positive tumors will be assessed.

Breast Cancer

Agendia481 participantsStarted Nov 2015

Palm Springs, California, United States • Miami, Florida, United States • Tampa, Florida, United States +14 more locations

COMPLETEDPhase 4< 1 mile

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

NCT00485953

Elderly, postmenopausal women with breast cancer on aromatase inhibitors are at increased risk of developing bone loss and osteoporosis. We postulate that in elderly, osteopenic postmenopausal women who are on aromatase inhibitor therapy, bisphosphonate therapy will (1) prevent bone loss at clinically relevant sites, such as the spine and hip and (2) decrease bone turnover.

Bone LossOsteoporosisBreast Cancer

Susan L. Greenspan109 participantsStarted Sep 2007

Pittsburgh, Pennsylvania, United States

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

Breast Cancer Trials in Other Cities

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Patient Preference Survey for Radiation Oncologists

Digital Mammography Screening Trial (ACRIN6652)

NOLAN: Naproxen or Loratadine and Neulasta

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

A Study Evaluating MM-310 in Patients With Solid Tumors

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer

Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer

Other Conditions in Pittsburgh